| Date Filed | Type | Description |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
4
| Arkowitz David (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 8,386 shares
@ $7.12, valued at
$59.7k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 10,000 options to buy
@ $9.28, valued at
$92.8k
Disposed of 5,500 options to buy
@ $9.05, valued at
$49.8k
Disposed of 4,386 warrants
@ $10.79, valued at
$47.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 02/07/2023 |
4
| Arkowitz David (CFO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 42,500 restricted stock units
@ $0
Granted 85,000 options to buy
@ $5.5, valued at
$467.5k
|
|
| 10/31/2022 |
4
| Arkowitz David (CFO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 42,500 shares
@ $0
Exercised 5,000 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| Arkowitz David (CFO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 63,492 shares
@ $3.15, valued at
$200k
|
|
| 06/22/2022 |
4
| Arkowitz David (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $3.41, valued at
$68.2k
|
|
| 02/08/2022 |
4
| Arkowitz David (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 190,000 options to buy
@ $7.38, valued at
$1.4M
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Arkowitz David (Director) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Granted 14,800 options to buy
@ $15.26, valued at
$225.8k
|
|
| 06/01/2021 |
4
| Arkowitz David (CFO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 270,000 options to buy
@ $20.19, valued at
$5.5M
Granted 5,000 restricted stock units
@ $0 |
|
| 06/01/2021 |
3
| Arkowitz David (CFO) has filed a Form 3 on Seres Therapeutics, Inc. |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Arkowitz David (Director) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Granted 4,347 shares
@ $23, valued at
$100k
|
|
| 11/23/2020 |
4
| Arkowitz David (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed of 1,096 warrants
@ $43.16, valued at
$47.3k
|
|
| 07/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Arkowitz David (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Arkowitz David (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 2,413 shares
@ $10.88, valued at
$26.3k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| Arkowitz David (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 3,095 shares
@ $0 |
|
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| Arkowitz David (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 4,179 shares
@ $0 |
|
| 07/11/2019 |
4
| Arkowitz David (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $4.62, valued at
$34.7k
|
|
| 07/01/2019 |
4
| Arkowitz David (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 3,896 shares
@ $0 |
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| Arkowitz David (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 2,500 shares
@ $11.0507, valued at
$27.6k
|
|
| 05/15/2019 |
4
| Arkowitz David (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 4,000 shares
@ $11.99, valued at
$48k
|
|
| 05/09/2019 |
4
| Arkowitz David (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Sold 2,248 shares
@ $10.06, valued at
$22.6k
|
|
| 04/02/2019 |
4
| Arkowitz David (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 1,370 shares
@ $0 |
|
| 03/08/2019 |
4
| Arkowitz David (Director) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Granted 30,600 options to buy
@ $4.07, valued at
$124.5k
|
|
|